ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AVRN Anteris Technologies Ltd

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Anteris Technologies Ltd ASX:AVRN Australian Stock Exchange Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Avitar Common Stock Now Trading on OTC Bulletin Board

21/09/2005 2:46pm

PR Newswire (US)


Anteris Technologies (ASX:AVRN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Anteris Technologies Charts.
CANTON, Mass., Sept. 21 /PRNewswire-FirstCall/ -- Avitar, Inc. (OTC:AVRN.OB) (BULLETIN BOARD: AVRN.OB) (or the "Company") is pleased to announce that NASD has approved the Company's application for its Common Stock to be quoted on the Bulletin Board. Quotation for trading on the Bulletin Board began September 20, 2005. The trading symbol is AVRN.OB. The OTC Bulletin Board is a regulated quotation service that displays real-time quotes, last-sale prices, and volume information in over-the-counter securities. Securities quoted on the Bulletin Board are subject to filing requirements with the Securities and Exchange Commission. The National Association of Securities Dealers, a self-regulatory organization of the securities industry, oversees both OTC Bulletin Board and the NASDAQ stock market. "We are pleased to announce the approval of the quotation of our Common Stock on the OTC Bulletin Board," commented Peter P. Phildius, CEO of Avitar, Inc. "As was previously announced on August 25, 2005, it has been our intention to be quoted on the NASD OTC Bulletin Board in order to provide our shareholders with a more readily accessible market presence." About Avitar Avitar, Inc. develops, manufactures and markets innovative and proprietary products. Their field includes the oral fluid diagnostic market, the disease and clinical testing market, and customized polyurethane applications used in the wound dressing industry. Avitar manufactures ORALscreen(R), the world's first non-invasive, rapid, onsite oral fluid test for drugs-of-abuse, as well as HYDRASORB(R), an absorbent topical dressing for moderate to heavy exudating wounds. Avitar is also developing diagnostic strategies for disease and clinical testing in the estimated $25 billion in-vitro diagnostics market. Conditions targeted include influenza, diabetes, and pregnancy. For more information, see Avitar's website at http://www.avitarinc.com/. Safe Harbor Statement. This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission. In view of such risks and uncertainties, the Company's actual results could differ materially from those anticipated in such forward looking statements. Company Contact: PR Contact: Jay C. Leatherman, CFO Monica Pandolfi Avitar, Inc. Shift Communications 781-821-2440 617-681-1235 http://www.avitarinc.com/ IR Contact: Lisa DeScenza LaVoie Group 617-688-3088 DATASOURCE: Avitar, Inc. CONTACT: Jay C. Leatherman, CFO of Avitar, Inc., +1-781-821-2440, ; or PR Contact: Monica Pandolfi of Shift Communications, +1-617-681-1235, ; or IR Contact: Lisa DeScenza of LaVoie Group, +1-617-688-3088, Web site: http://www.avitarinc.com/

Copyright

1 Year Anteris Technologies Chart

1 Year Anteris Technologies Chart

1 Month Anteris Technologies Chart

1 Month Anteris Technologies Chart